BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 14682223)

  • 1. [Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge].
    Rubinsztajn R; Wrońska J; Chazan R
    Pol Arch Med Wewn; 2003 Aug; 110(2):849-54. PubMed ID: 14682223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
    Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
    Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
    Micheletto C; Visconti M; Tognella S; Trevisan F; Dal Negro RW
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls.
    Micheletto C; Visconti M; Tognella S; Facchini FM; Dal Negro RW
    Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):20-3. PubMed ID: 16544584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary leukotriene E4 in bronchial asthma.
    Smith CM; Hawksworth RJ; Thien FC; Christie PE; Lee TH
    Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.
    Nizankowska E; Bestyńska-Krypel A; Cmiel A; Szczeklik A
    Eur Respir J; 2000 May; 15(5):863-9. PubMed ID: 10853850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
    Schapowal AG; Simon HU; Schmitz-Schumann M
    Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity.
    Divekar R; Hagan J; Rank M; Park M; Volcheck G; O'Brien E; Meeusen J; Kita H; Butterfield J
    J Allergy Clin Immunol Pract; 2016; 4(4):665-70. PubMed ID: 27080204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge.
    Mita H; Higashi N; Taniguchi M; Higashi A; Akiyama K
    Clin Exp Allergy; 2004 Aug; 34(8):1262-9. PubMed ID: 15298568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
    Mita H; Endoh S; Kudoh M; Kawagishi Y; Kobayashi M; Taniguchi M; Akiyama K
    Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma.
    Yoshida S; Nakagawa H; Yamawaki Y; Sakamoto H; Akahori K; Nakabayashi M; Sakamoto M; Hasegawa H; Shoji T; Tajimab T; Amayasu H
    Int Arch Allergy Immunol; 1998 Oct; 117(2):146-51. PubMed ID: 9784659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
    Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K
    J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
    Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental studies on the measurement of urinary leukotriene E4].
    Oosaki R; Mizushima Y; Kawasaki A; Kobayashi M; Mita H; Maeda Y; Hayakawa T; Yamada T; Shida T
    Arerugi; 1994 Feb; 43(2 Pt 1):127-33. PubMed ID: 8147715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P; Armetti L; Gambaro G; Pieroni MG; Refini RM; Sala A; Vaghi A; Folco GC; Bianco S; Robuschi M
    Am J Respir Crit Care Med; 1996 Feb; 153(2):572-5. PubMed ID: 8564100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma.
    Nasser SM; Patel M; Bell GS; Lee TH
    Am J Respir Crit Care Med; 1995 May; 151(5):1326-30. PubMed ID: 7735581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects.
    Christie PE; Tagari P; Ford-Hutchinson AW; Black C; Markendorf A; Schmitz-Schumann M; Lee TH
    Am Rev Respir Dis; 1992 Dec; 146(6):1531-4. PubMed ID: 1333741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of nasal polyps and the corresponding urinary LTE4 levels in severe compared to mild and moderate asthma.
    Micheletto C; Visconti M; Trevisan F; Tognella S; Bertacco S; Dal Negro RW
    Eur Ann Allergy Clin Immunol; 2010 Jun; 42(3):120-4. PubMed ID: 20648775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of urinary leukotriene E4 levels in asymptomatic bronchial asthma].
    Yamamoto H; Kuramitsu K; Houya I; Maruo H; Sakata K; Tabe K; Kimura I; Inoue K; Shibasaki M; Yamamoto K; Sakamoto Y; Matsuo H
    Arerugi; 1996 Oct; 45(10):1106-11. PubMed ID: 8958657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.